Is hydroxychloroquine beneficial for COVID-19 patients?

被引：61

作者：

Li, Xing ^{[1
]}

Wang, Ying ^{[2
]}

Agostinis, Patrizia ^{[3
]}

Rabson, Arnold ^{[4
]}

Melino, Gerry ^{[5
]}

Carafoli, Ernesto ^{[6
]}

Shi, Yufang ^{[2
,7
]}

Sun, Erwei ^{[1
,8
]}

机构：

[1] Southern Med Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, 183 Zhongshan Ave West, Guangzhou 510630, Guangdong, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China

[3] Katholieke Univ Leuven, VIB KU Leuven Ctr Canc Biol, Leuven, Belgium

[4] Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA

[5] Univ Roma Tor Vergata, TOR, I-00133 Rome, Italy

[6] Univ Padua, Venetian Inst Mol Med, Rome, Italy

[7] Soochow Univ, State Key Lab Radiat Med & Protect, Affiliated Hosp 1, Inst Translat Med,Med Coll, Suzhou, Peoples R China

[8] Southern Med Univ, Shunde Hosp, Dept Rheumatol & Immunol, Peoples Hosp Shunde 1, Foshan 528000, Guangdong, Peoples R China

来源：

CELL DEATH & DISEASE | 2020年 / 11卷 / 07期

关键词：

ANTIMALARIAL-DRUGS; CHLOROQUINE; INFECTION; INHIBIT; CELLS;

D O I：

10.1038/s41419-020-2721-8

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar cases rapidly emerged around the world(1-3), the World Health Organization (WHO) declared a public health emergency of international concern on January 30, 2020 and pronounced the rapidly spreading coronavirus outbreak as a pandemic on March 11, 2020(4). The virus has reached almost all countries of the globe. As of June 3, 2020, the accumulated confirmed cases reached 6,479,405 with more than 383,013 deaths worldwide. The urgent and emergency care of COVID-19 patients calls for effective drugs, in addition to the beneficial effects of remdesivir(5), to control the disease and halt the pandemic.

引用

页数：6

共 50 条

[31] Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
Alizargar, Javad
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 38
[32] The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
Ehud Chorin
Matthew Dai
Eric Shulman
Lalit Wadhwani
Roi Bar-Cohen
Chirag Barbhaiya
Anthony Aizer
Douglas Holmes
Scott Bernstein
Michael Spinelli
David S. Park
Larry A. Chinitz
Lior Jankelson
Nature Medicine, 2020, 26 : 808 - 809
[33] Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
Reactions Weekly, 2020, 1828 (1) : 9 - 9
[34] COVID-19 infection also occurs in patients taking hydroxychloroquine
Lahouati, M.
Meriglier, E.
Martin, L.
Bouchet, S.
Desclaux, A.
Bonnet, F.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 2014 - 2015
[35] HYDROXYCHLOROQUINE AND AZITHROMYCIN COMBINATION COULD BE LETHAL TO COVID-19 PATIENTS
Mohammad, Firdous Sayeed
Karmakar, Varnita
Irfan, Zainab
FARMACIA, 2020, 68 (03) : 384 - 389
[36] Use of Hydroxychloroquine in Patients with COVID-19: A Retrospective Observational Study
Lotfy, Samah Mohamad
Abbas, Ahmad
Shouman, Waheed
TURKISH THORACIC JOURNAL, 2021, 22 (01): : 62 - 66
[37] Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine
Tejada Cifuentes, Francisco
Lloret Callejo, Angeles
Tirado Pelaez, Maria Jose
Rubio Pulido, Olga
Ruiz-Morote Aragon, Marta
Fernandez Urrusuno, Rocio
Munoz Carreras, Maria Isabel
Mendez Esteban, Maria Isabel
Maestre Sanchez, Victoria
Garcia Bonilla, Antonio
Paredero Dominguez, Jose Manuel
Arroyo Pineda, Virginia
Marco Tejon, Esther
Romero Candel, Gregorio
Fernandez Marchante, Ana Isabel
Marco del Rio, Jose
Ortiz Martin, Teresa
Lopez Sanchez, Piedad
MEDICINA CLINICA, 2021, 156 (04): : 166 - 171
[38] QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine
Monzani, Alice
Genoni, Giulia
Scopinaro, Alice
Pistis, Gianfranco
Kozel, Daniela
Secco, Gioel Gabrio
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (06)
[39] The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
Ayerbe, Luis
Risco-Risco, Carlos
Ayis, Salma
INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (08) : 1501 - 1506
[40] Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
Lamback, Elisa Baranski
de Oliveira, Monica Amorim
Haddad, Andrea Ferreira
Marcondes Vieira, Andre Filipe
Ferreira Neto, Armando Leao
Maia, Taciana da Silva
Chrisman, Juliana de Rezende
de Mello Spineti, Pedro Pimenta
de Mattos, Marco Antonio
Costa, Eduardo
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2021, 25 (02):

← 1 2 3 4 5 →